CVS Competitors

Stocks . Mexico . 
Stock . CVS Health
CVS Stock  MXN 1,218  31.00  2.61%   
CVS Health competes with Glencore Plc, IShares Trust, US Bancorp, American Express, and Fluor; as well as few others. The company operates under Healthcare sector and is part of Health Care Plans industry. Analyzing CVS Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of CVS Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out CVS Health Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of CVS Health competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
1,2161,2181,220
Details
Intrinsic
Valuation
LowRealHigh
1,0101,0121,340
Details
Naive
Forecast
LowNextHigh
1,2731,2761,278
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1,0741,1411,209
Details

CVS Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between CVS Health and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of CVS and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of CVS Health does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
AXP
+ 0.9
IYW
AXP
+ 0.76
USB
USB
+ 0.74
IYW
FLR
+ 0.72
USB
VRTX
+ 0.61
USB
FLR
+ 0.6
GLENN
  
High negative correlations   
ODP
- 0.0
LYGN
ODP
- 0.0
ITB
LYGN
- 0.0
ITB
ODP
- 0.0
VRTX
LYGN
- 0.0
VRTX
ODP
- 0.0
FLR

Risk-Adjusted Indicators

There is a big difference between CVS Stock performing well and CVS Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CVS Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

CVS Health Competitive Analysis

The better you understand CVS Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, CVS Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across CVS Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CVS GLENN IYW USB AXP FLR VRTX ITB LYGN ODP
 2.61 
 1,218 
CVS
 0.00 
 89.89 
Glencore
 0.28 
 3,251 
IShares
 0.00 
 1,016 
USB
 0.49 
 6,180 
American
 0.00 
 985.27 
Fluor
 1.63 
 9,266 
Vertex
 1.14 
 2,464 
IShares
 0.00 
 49.50 
Lloyds
 0.00 
 826.00 
ODP
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Modest
OK
OK
OK
Good
Weak
Very Weak
Insignificant
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Low
Low
Low
Low
Low
Low
Above Average
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Fairly Valued
Fairly Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Sell
Cautious Hold
Strong Sell
Strong Sell
Strong Buy
Strong Sell
Strong Sell
Hold
Hold
Current Ratio
0.94
1.1
N/A
N/A
1.58
1.41
4.61
N/A
N/A
1.08
Net Asset
228.28 B
127.51 B
4.09 B
674.8 B
228 B
7.28 B
18.15 B
2.76 B
886.52 B
4.87 B
Profit Margin
0.0129
0.0646
N/A
0.26
0.15
-0.012
0.37
N/A
0.27
-0.0148
EBITDA
12.16 B
14.68 B
N/A
N/A
N/A
31.13 M
4.29 B
N/A
N/A
405 M
Operating Margin
0.0479
0.0844
N/A
0.35
0.19
0.0126
0.49
N/A
0.49
0.0337
Current Valuation
3.58 T
2.25 T
N/A
1.82 T
2.85 T
66.74 B
1.41 T
N/A
3384.03 T
49.97 B
Price To Book
1.83
1.76
4.2
1.61
4.76
2.33
6.07
1.89
0.63
1.22
Five Year Return
2.05
N/A
17.42
2.24
1.42
N/A
N/A
20.42
N/A
N/A
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
237.83 B
N/A
One Year Return
N/A
N/A
11.96
N/A
N/A
N/A
N/A
67.08
N/A
N/A
Beta
0.65
1.26
N/A
1.0
1.19
2.31
0.46
N/A
1.23
1.85
Number Of Employees
219 K
135 K
15
77 K
77.3 K
40.58 K
4.8 K
N/A
57.95 K
26 K
Equity Positions Weight
N/A
N/A
99.89
N/A
N/A
N/A
N/A
99.89
N/A
N/A
Shares Outstanding
1.28 B
12.68 B
N/A
1.53 B
743 M
142.09 M
257.09 M
N/A
16.85 B
45.81 M
Three Year Return
N/A
N/A
24.55
N/A
N/A
N/A
N/A
23.88
N/A
N/A
Cash Flow From Operations
16.18 B
8.86 B
N/A
9.87 B
14.64 B
25.33 M
2.64 B
N/A
(16.94 B)
323 M
Annual Yield
0.0272
0.0411
N/A
0.0394
0.0118
0.0861
N/A
N/A
0.0448
0.0525
Total Debt
50.48 B
25.72 B
N/A
39.83 B
43 B
1.17 B
893.85 M
N/A
N/A
193 M
Return On Equity
0.0568
0.39
N/A
0.11
0.32
0.0349
0.28
N/A
0.09
0.1
Z Score
26.2
36.4
N/A
21.0
34.8
40.0
N/A
N/A
N/A
N/A
Return On Asset
0.0418
0.0982
N/A
0.0094
0.0361
0.0133
0.17
N/A
0.005
0.0363
Book Value Per Share
54.63
3.64
N/A
28.71
33.26
11.61
54.13
N/A
2.1
32.07
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
521.05 B
N/A
Total Asset
228.28 B
127.51 B
4.09 B
674.8 B
228 B
7.28 B
18.15 B
2.76 B
886.52 B
4.87 B
Debt To Equity
159.2
77.2
N/A
N/A
1.54
1.56
0.097
N/A
N/A
144.8
Last Dividend Paid
2.2
0.26
N/A
1.88
2.08
N/A
N/A
N/A
0.021
N/A
Shares Owned By Institutions
82.77
42.36
N/A
73.18
86.99
98.76
96.96
N/A
2.04
99.62
Market Capitalization
2.13 T
1.53 T
N/A
1.4 T
2.5 T
76.15 B
1.46 T
N/A
817.65 B
37.25 B
Price To Earning
398.88
272.67
19.88
241.57
29.88
426.17
17.5
13.87
207.5
410.0
Price To Earnings To Growth
1.33
0.37
N/A
0.83
1.14
1.34
0.41
N/A
0.16
N/A
Price To Sales
8.1
6.85
3.0
59.47
44.64
6.38
180.7
0.91
46.05
4.42
Net Income
4.15 B
4.97 B
N/A
5.83 B
7.51 B
(440.17 M)
3.32 B
N/A
5.78 B
(208 M)
Earnings Per Share
58.33
22.24
N/A
69.33
185.07
8.53
238.31
N/A
5.12
70.4
Shares Owned By Insiders
0.4
9.84
N/A
0.12
0.14
0.79
0.2
N/A
N/A
2.58
Revenue
322.47 B
203.75 B
N/A
24.18 B
50.68 B
12.43 B
8.93 B
N/A
37.44 B
8.46 B
Ten Year Return
N/A
N/A
17.16
N/A
N/A
N/A
N/A
18.76
N/A
N/A
Working Capital
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
(283.22 B)
N/A
Cash And Equivalents
8.32 B
2.08 B
N/A
18.76 B
29.11 B
2.22 B
6.71 B
N/A
235.94 B
604 M
Cash Per Share
6.41
0.15
N/A
11.9
36.64
15.79
25.86
N/A
13.97
1.11
Gross Profit
53.46 B
12.38 B
N/A
22.21 B
28.78 B
411.6 M
7.55 B
N/A
16.96 B
1.86 B
Day Typical Price
1213.67
89.89
3251.0
1015.5
6170.0
985.27
9266.41
2464.08
49.5
826.0
Accumulation Distribution
0.0107
N/A
N/A
N/A
0.0049
N/A
N/A
N/A
N/A
N/A
Market Facilitation Index
13.0
N/A
N/A
N/A
30.0
N/A
N/A
N/A
N/A
N/A
Daily Balance Of Power
2.384615
0.0
9.2 T
0.0
1.0
0.0
9.2 T
9.2 T
0.0
0.0
Period Momentum Indicator
31.0
N/A
9.0
N/A
30.0
N/A
148.99
27.72
N/A
N/A
Rate Of Daily Change
1.03
1.0
1.0
1.0
1.0
1.0
1.02
1.01
1.0
1.0
Day Median Price
1211.5
89.89
3251.0
1015.5
6165.0
985.27
9266.41
2464.08
49.5
826.0
Price Action Indicator
22.0
N/A
4.5
N/A
30.0
N/A
74.49
13.86
N/A
N/A
Coefficient Of Variation
1425.81
812.4
804.9
615.16
460.5
782.38
2550.21
1075.3
N/A
N/A
Mean Deviation
1.67
0.0435
1.11
1.21
1.4
1.7
1.15
1.04
N/A
N/A
Jensen Alpha
0.1854
0.0122
0.1642
0.4585
0.4192
0.6794
0.1081
0.1157
N/A
N/A
Total Risk Alpha
(0.22)
(0.02)
(0.06)
0.0084
0.1103
(0.17)
(0.29)
(0.12)
N/A
N/A
Sortino Ratio
0.0183
N/A
0.037
0.0949
0.1534
N/A
(0.01)
0.0167
N/A
N/A
Downside Variance
5.06
N/A
2.89
8.7
3.65
N/A
19.47
4.41
N/A
N/A
Standard Deviation
2.42
0.1792
1.54
2.51
1.94
5.9
2.39
1.76
N/A
N/A
Kurtosis
6.5
66.0
0.591
13.15
2.16
54.27
7.76
5.38
N/A
N/A
Potential Upside
3.44
N/A
2.86
5.58
3.37
N/A
3.97
3.0
N/A
N/A
Treynor Ratio
(0.74)
(8.61)
1.25
(0.79)
(6.70)
1.37
(0.40)
0.4794
N/A
N/A
Maximum Drawdown
18.37
1.46
7.88
16.15
12.33
53.68
18.57
11.21
N/A
N/A
Variance
5.86
0.0321
2.38
6.31
3.78
34.78
5.69
3.1
N/A
N/A
Market Risk Adjusted Performance
(0.73)
(8.60)
1.26
(0.78)
(6.69)
1.38
(0.39)
0.4894
N/A
N/A
Risk Adjusted Performance
0.0604
0.0614
0.1
0.1312
0.172
0.1064
0.0368
0.0767
N/A
N/A
Skewness
0.9754
8.12
(0)
2.88
0.3412
7.1
(0.76)
1.25
N/A
N/A
Semi Deviation
2.1
N/A
1.25
0.7963
1.39
N/A
1.95
1.09
N/A
N/A
Information Ratio
0.017
(0.59)
0.0408
0.1114
0.151
0.106
(0.01)
0.0199
N/A
N/A
Value At Risk
(2.93)
N/A
(2.56)
(1.50)
(2.54)
N/A
(3.65)
(3.10)
N/A
N/A
Expected Short fall
(1.84)
N/A
(1.29)
(6.10)
(1.67)
N/A
(2.63)
(2.06)
N/A
N/A
Downside Deviation
2.25
N/A
1.7
2.95
1.91
N/A
4.41
2.1
N/A
N/A
Semi Variance
4.41
N/A
1.57
0.634
1.94
N/A
3.8
1.18
N/A
N/A

CVS Health Competition Performance Charts

Five steps to successful analysis of CVS Health Competition

CVS Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by CVS Health in relation to its competition. CVS Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of CVS Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact CVS Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to CVS Health, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your CVS Health position

In addition to having CVS Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Latest Losers Thematic Idea Now

Latest Losers
Latest Losers Theme
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Losers theme has 239 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Losers Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for CVS Stock Analysis

When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY